Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine for prevention of recurrent placental insufficiency complications in pregnancy
IRCT20250323065146N1Phase 3Completed
- Sponsor
- Yasouj University of Medical Sciences
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of hydroxychloroquine in placental insufficiency (2 arms), sponsored by Yasouj University of Medical Sciences. Primary endpoint: Birth weight. Started Sep 2025; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
placental insufficiency
Beyond the preview
Go deeper on IRCT20250323065146N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250323065146N1.